OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma.
Lu Y, Li Y, Yu J, Meng S, Bi C, Guan Q, Li L, Qiu L, Qian Z, Zhou S, Gong W, Meng B, Ren X, Armitage J, Zhang H, Fu K, Wang X.
Lu Y, et al. Among authors: qian z.
Clin Immunol. 2023 Jun;251:109637. doi: 10.1016/j.clim.2023.109637. Epub 2023 May 5.
Clin Immunol. 2023.
PMID: 37150239